Trials / Unknown
UnknownNCT01637688
Growth and Plasma Amino Acids in Infants With CMPA and Treated With a Newly Innovated Amino Acid Formula
Growth and Plasma Amino Acid Levels in Infants With Cow's Milk Protein Allergy and Treated With a Newly Innovated Amino Acid Formula (NAAF) Compared to a Commercial Amino Acid Formula (AAF)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (actual)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 1 Week – 6 Months
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine growth and protein status of infants with cow's milk protein allergy and treated with a newly innovated amino acid formula compared to those with a commercial amino acid formula.
Detailed description
Severe cases of cow's milk protein allergy are treated with the amino acid formula. The amino acid formula is composed of essential and non-essential amino acids, vegetable oils with or without MCT oil, and glucose polymer from various carbohydrate sources. Such formula is also fortified by minerals, trace elements,and vitamins.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Comparison of treatment with different amino acid formulas | Growth and amino acid status of a newly innovated amino acid formula (NAAF) and a commercial amino acid formula (AAF) |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2023-06-30
- Completion
- 2023-07-31
- First posted
- 2012-07-11
- Last updated
- 2023-03-24
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01637688. Inclusion in this directory is not an endorsement.